NewAmsterdam Pharma Company
NAMS
#3764
Rank
NZ$4.50 B
Marketcap
$40.98
Share price
-1.81%
Change (1 day)
20.94%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) - Cash on Hand

Cash on Hand as of December 2024 : NZ$1.46 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company has NZ$1.46 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

NewAmsterdam Pharma Company - Cash on Hand chart (from 2023 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$1.47 B174.76%
2023-12-31NZ$0.53 B-31.88%
2022-12-31NZ$0.79 B692.87%
2021-12-31NZ$99.66 M504.71%
2020-12-31NZ$16.48 M